LOGIN
Dronabinol is not better than placebo for ALS cramps and fasciculations over 2 weeks
October 2018
Dronabinol is not better than placebo for ALS cramps and fasciculations over 2 weeks
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial
J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1135-40. doi: 10.1136/jnnp.2009.200642Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
27 patients with amyotrophic lateral sclerosis (ALS) were randomized to receive either 5 mg dronabinol twice daily or placebo for 2 weeks in a randomized sequence. The purpose of this study was to determine if dronabinol decreases frequency and intensity of cramps and fasciculations compared to placebo, and if there are any improvements in sleep quality, functional ability, appetite and depression...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.